Background Breast cancer is a leading cause of mortality for women in all racial/ethnic groups. We compared use of mammography by race/…
In two important health policy contexts – private plans in Medicare and the new state-run “Exchanges” created as part of the Affordable…
Objective: There is limited information on the protective value of
Medicare Part D low-income subsidies ( LIS). We compared responses to…
Background: Relative to traditional fee-for-service Medicare, managed care plans caring for Medicare beneficiaries may be better positioned…
Geographic variation in per-beneficiary Medicare spending that cannot be explained by wages and the prices of other inputs to health care…
/publications/adverse-clinical-events-among-medicare-beneficiaries-using-antipsychotic-drugs-linking
Objective: Medicare Part D provides formulary protections for antipsychotics but does not exempt these drugs from cost-sharing. We…
Health care in the United States is more expensive than in other developed countries, costing $2.7 trillion in 2011, or 17.9 percent of the…
We investigate the role of physician agency and competition in determining health care supply and patient outcomes. A 2005 change to…
With quality-of-care bonus
payments now available for Medicare Advantage health maintenance
organizations (HMOs) and for accountable…
Identifying policies that will cut or constrain US health care spending and spending growth dominates reform efforts, yet little is known…